# Retraining and Control Therapy (ReACT) R33 Phase

> **NCT06007053** · NA · RECRUITING · sponsor: **University of Alabama at Birmingham** · enrollment: 160 (estimated)

## Conditions studied

- Convulsion, Non-Epileptic

## Interventions

- **BEHAVIORAL:** ReACT
- **BEHAVIORAL:** Supportive Therapy

## Key facts

- **NCT ID:** NCT06007053
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-09
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2026-03-17

## Collaborators

- National Institute of Mental Health (NIMH)

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06007053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06007053, "Retraining and Control Therapy (ReACT) R33 Phase". Retrieved via AI Analytics 2026-07-23 from https://api.ai-analytics.org/clinical/NCT06007053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*